[MDGL] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
10-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -39.14%
YoY- -147.03%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -49,023 -19,699 -6,460 -8,347 -3,379 -19,800 -22,286 14.02%
Tax -1,319 0 -1,166 0 -110 0 0 -
NP -49,023 -19,699 -6,460 -8,347 -3,379 -19,800 -22,286 14.02%
Tax Rate - - - - - - - -
Total Cost 49,023 19,699 6,460 8,347 3,379 19,800 22,286 14.02%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -3.18 -1.28 -0.45 -0.69 -19.18 -5.24 -8.29 -14.74%
EPS Diluted -3.18 -1.28 -0.45 -0.69 -19.18 -5.24 -8.29 -14.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.